4884 — Kringle Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- ¥6bn
- ¥4bn
- ¥80m
Annual cashflow statement for Kringle Pharma, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -116 | -300 | -330 | -853 | -755 |
| Non-Cash Items | -54.8 | -59.3 | -71.6 | -35.7 | -62 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 24.7 | -202 | 418 | 199 | 156 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -146 | -561 | 15.8 | -689 | -661 |
| Other Investing Cash Flow Items | — | — | -254 | -121 | -121 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -254 | -121 | -121 |
| Financing Cash Flow Items | — | -16.3 | 1.04 | 1.24 | -0.032 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 2,083 | 596 | 603 | 69.2 | 838 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,936 | 35 | 365 | -741 | 55.7 |